Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.
Read the full blog <a href="https://blog.sid.business/p/investing-in-pharma-part-1-divis" target="_blank" rel="noopener noreferer">here</a>

Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs. Read the full blog here

Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.
Read the full blog <a href="https://blog.sid.business/p/investing-in-pharma-part-1-divis" rel="noopener noreferrer">here</a>

Share Investing in Pharma (Part 1) - Divi's Laboratories

Sign up to save your podcasts

Investing in Pharma (Part 1) - Divi's Laboratories

Investing in Pharma (Part 1) - Divi's Laboratories